Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Louisa Jordison

Louisa joined Sygnature in February 2019 as Director of Strategic Planning. In 2021, she took on the role of Chief Financial Officer, entering our boardroom with an extremely strong finance background.

Prior to joining us, Louisa spent 12 years at Deloitte in the Corporate Finance Advisory team, advising clients on a wide range of corporate transactions including acquisitions, disposals and private equity transactions. More recently, she was the Senior Strategic Planning Manager at Experian, where she was responsible for driving the annual strategic market planning process for the UK business.

Louisa is a member of the Institute of Chartered Accountants in England and Wales (ICAEW), having qualified with KPMG in 2003, and has a BA in Business Economics from the University of Exeter.